195 related articles for article (PubMed ID: 26473922)
1. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
[TBL] [Abstract][Full Text] [Related]
2. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
4. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
Basu D; Tumer NE
Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
[TBL] [Abstract][Full Text] [Related]
5. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
[TBL] [Abstract][Full Text] [Related]
6. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.
Lentz EK; Leyva-Illades D; Lee MS; Cherla RP; Tesh VL
Infect Immun; 2011 Sep; 79(9):3527-40. PubMed ID: 21708996
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
Jeong KI; Tzipori S; Sheoran AS
J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
[TBL] [Abstract][Full Text] [Related]
8. Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.
Lee KS; Lee J; Lee P; Kim CU; Kim DJ; Jeong YJ; Park YJ; Tesh VL; Lee MS
Cell Microbiol; 2020 Nov; 22(11):e13249. PubMed ID: 32772454
[TBL] [Abstract][Full Text] [Related]
9. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
[TBL] [Abstract][Full Text] [Related]
10. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli.
Vinh PT; Shinohara Y; Yamada A; Duc HM; Nakayama M; Ozawa T; Sato J; Masuda Y; Honjoh KI; Miyamoto T
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470657
[TBL] [Abstract][Full Text] [Related]
11. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
[TBL] [Abstract][Full Text] [Related]
12. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
[TBL] [Abstract][Full Text] [Related]
13. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.
Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S
Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301
[TBL] [Abstract][Full Text] [Related]
14. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
[TBL] [Abstract][Full Text] [Related]
16. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
17. Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.
Harrison LM; van den Hoogen C; van Haaften WC; Tesh VL
Infect Immun; 2005 Jan; 73(1):403-12. PubMed ID: 15618178
[TBL] [Abstract][Full Text] [Related]
18. Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with polyuria.
Sugatani J; Komiyama N; Mochizuki T; Hoshino M; Miyamoto D; Igarashi T; Hoshi S; Miwa M
Life Sci; 2002 May; 71(2):171-89. PubMed ID: 12031687
[TBL] [Abstract][Full Text] [Related]
19. Construction of a novel bioluminescent reporter system for investigating Shiga toxin expression of enterohemorrhagic Escherichia coli.
Shimizu T; Ohta Y; Tsutsuki H; Noda M
Gene; 2011 Jun; 478(1-2):1-10. PubMed ID: 21262333
[TBL] [Abstract][Full Text] [Related]
20. Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions.
Álvarez RS; Sacerdoti F; Jancic C; Paton AW; Paton JC; Ibarra C; Amaral MM
PLoS One; 2016; 11(6):e0158180. PubMed ID: 27336788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
